T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.72% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
ESAB
ESAB
$5.29B
| $5.14M | ﹤0.01% |
109,618
+37,456
| +52% | +$1.57M |
|
1177
Ciena
CIEN
$62.7B
| $5.13M | ﹤0.01% |
100,625
-21,957
| -18% | -$993K |
|
1178
National Fuel Gas
NFG
$7.77B
| $5.11M | ﹤0.01% |
80,696
-9,705
| -11% | -$625K |
|
1179
Ryder
R
$10.1B
| $5.11M | ﹤0.01% |
61,100
+2,315
| +4% | +$194K |
|
1180
Idacorp
IDA
$8.16B
| $5.05M | ﹤0.01% |
46,795
+10,250
| +28% | +$1.06M |
|
1181
Sensata Technologies
ST
$6.72B
| $5.05M | ﹤0.01% |
124,973
-9,160
| -7% | -$382K |
|
1182
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $5.03M | ﹤0.01% |
61,985
-12,100
| -16% | -$982K |
|
1183
Senti Biosciences Holdings
SNTI
$12M
| $5.01M | ﹤0.01% |
355,402
-46,146
| -11% | -$1.13M |
|
1184
Owens Corning
OC
$12.3B
| $4.99M | ﹤0.01% |
58,476
-560
| -0.9% | -$49.1K |
|
1185
Helen of Troy
HELE
$696M
| $4.98M | ﹤0.01% |
44,895
-55,439
| -55% | -$5.4M |
|
1186
Essential Utilities
WTRG
$11.3B
| $4.98M | ﹤0.01% |
104,259
-4,112
| -4% | -$186K |
|
1187
NNN REIT
NNN
$8.87B
| $4.96M | ﹤0.01% |
108,469
+1,245
| +1% | +$54.1K |
|
1188
Regal Rexnord
RRX
$11.4B
| $4.95M | ﹤0.01% |
41,267
+1,468
| +4% | +$192K |
|
|
ATRI
1189
DELISTED
Atrion Corp
ATRI
| $4.91M | ﹤0.01% |
8,777
+124
| +1% | +$74.9K |
|
1190
Seacoast Banking Corp of Florida
SBCF
$3.44B
| $4.91M | ﹤0.01% |
157,284
-12,947
| -8% | -$412K |
|
1191
Immunovant
IMVT
$8.64B
| $4.9M | ﹤0.01% |
+275,999
| New | +$3.48M |
|
1192
Jones Lang LaSalle
JLL
$17B
| $4.89M | ﹤0.01% |
30,685
-677
| -2% | -$108K |
|
1193
ONE Gas
OGS
$5.05B
| $4.87M | ﹤0.01% |
64,340
+10,978
| +21% | +$847K |
|
1194
Voyager Therapeutics
VYGR
$197M
| $4.86M | ﹤0.01% |
797,321
-46,390
| -5% | -$264K |
|
|
LBPH
1195
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $4.78M | ﹤0.01% |
1,510,961
+1,186
| +0.1% | +$4.76K |
|
1196
Quaker Houghton
KWR
$2.95B
| $4.74M | ﹤0.01% |
28,377
-2,405
| -8% | -$404K |
|
1197
Samsara
IOT
$24B
| $4.73M | ﹤0.01% |
380,338
+294,787
| +345% | +$3.36M |
|
1198
Korn Ferry
KFY
$4.28B
| $4.7M | ﹤0.01% |
92,798
+16,213
| +21% | +$862K |
|
|
ABB
1199
DELISTED
ABB Ltd
ABB
| $4.69M | ﹤0.01% |
154,004
+10,476
| +7% | +$305K |
|
1200
Envista
NVST
$4.61B
| $4.67M | ﹤0.01% |
138,640
-9,203
| -6% | -$315K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.